Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
08/2003
08/28/2003WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2003WO2003070230A1 Use of agents that modulate pde11a activity
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070184A2 Sodium channel blockers
08/28/2003WO2003070182A2 Sodium channel blockers
08/28/2003WO2003049744B1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
08/28/2003WO2003045315A3 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
08/28/2003WO2003031447A3 Pyrimidine derivatives
08/28/2003WO2003014321A3 Compositions and methods for modulation of darpp-32 phosphorylation
08/28/2003WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist
08/28/2003WO2003002058A3 Bone anabolic compounds and methods of use
08/28/2003WO2002102359A3 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity
08/28/2003WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002041880A3 Use of pyrazolo[4,3-d]pyrimidines
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2001085147A3 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
08/28/2003US20030162771 Have an antagonistic activity with respect to corticotropin releasing factor
08/28/2003US20030162767 Novel 1,3-dihydro-2h-indol-2-one derivatives, method for preparing same and pharmaceutical compositions containing them
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161845 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
08/28/2003US20030161811 Method for treating cervical cancer
08/28/2003CA2477117A1 Pyrrolopyrimidine derivative
08/28/2003CA2476837A1 Sodium channel blockers
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476427A1 Partial peptide mimetics and methods
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003CA2468631A1 Prostaglandin composition for the treatment of erectile dysfunction
08/28/2003CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
08/27/2003EP1338600A1 Fused 1,2,4-Thiadiazine derivatives, their preparation and use
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337518A1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
08/27/2003EP1337282A2 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
08/27/2003EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003EP1337247A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
08/27/2003EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
08/27/2003EP1140889B1 Compounds and methods for modulation of estrogen receptors
08/27/2003EP0891363B1 Heterocyclic compounds and their preparation and use
08/27/2003EP0735881B1 Means and method for hormonal contraception and/or the treatment of acne
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439012A 2-zminoalkyl-thieno [2,3-D] pyrimidines
08/27/2003CN1439011A 5-aminoalkyl-pyrazolo [4,3-d] pyrimidines with phosphodiesterase v-inhibiting effect
08/27/2003CN1438994A Polymorphic forms/hydrates of N-[4-(3-chloro-4-fluoro-phenylamino)-7- (3-morpholin-4-ylpropoxy)-quinazolin-6-Yl] acrylamide dihydrochloride
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/27/2003CN1438893A Therapeutical use of sophora flavescens or sophora subprostrated extracts
08/27/2003CN1438884A Therapeutic combinations of fatty acids
08/27/2003CN1438315A Beta-lactamase/amino-glucosidic passive zyme interfused gene, its expressed products and composition thereof and use
08/27/2003CN1438306A Efficient biological lubricant and preparation method
08/27/2003CN1438247A Anti-mastitis causative-agent composite yolk antiboy for milk cow and its preparation and use
08/27/2003CN1438217A Bearing-resisting compound and preparing method
08/27/2003CN1438035A Composition for promoting sexual gland growth of male fish
08/27/2003CN1438034A Composition for promoting sexual gland growth of female fish
08/27/2003CN1438027A Chinese medicine for treating breast disease
08/27/2003CN1438012A Medicine for treating functional disturbance uterine hemorrhage
08/27/2003CN1437999A Chinese medicine for treating infantile uterus
08/27/2003CN1437991A Medicine for treating bacterial vaginal disease
08/27/2003CN1437983A Plaster for treating dysmenorrhoea and preparation method
08/27/2003CN1437978A Chinese medicine for gynaecological tumor and preparation method
08/27/2003CN1437955A Use of refined fur-seal oil in medicine for preventing and treating climacteric metancholia and menalgia
08/27/2003CN1437945A Central medicine preparation and preparation method
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/27/2003CN1119148C Use of alpha 1L agonists in treatment of in continence
08/26/2003US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases
08/26/2003US6610745 Use of 2-hydroxy-4-trifluoromethyl-benzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-KS
08/26/2003US6610725 Fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
08/26/2003US6610688 For therapy of blood vessel proliferative disorders; fibrotic disorders; mesangial cell proliferative disorders; metabolic disorders; allergies; asthma; thrombosis; nervous system diseases; and cancer
08/26/2003US6610685 Fused indole derivatives
08/26/2003US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
08/26/2003US6610657 Reducing semen migration using polypeptides which inhibit binding of protein kinases; contraceptives; antifertility agents
08/26/2003US6610652 Administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone
08/22/2003CA2418930A1 Use of agents that modulate pde11a activity
08/21/2003WO2003068975A1 ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION
08/21/2003WO2003068817A1 Management of mucosal viscosity by tff monomer peptides
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068771A1 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
08/21/2003WO2003068769A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
08/21/2003WO2003068760A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
08/21/2003WO2003068752A1 Benzenesulfonamide derivatives as antipsychotic agents
08/21/2003WO2003068749A1 Vanilloid receptor modulators
08/21/2003WO2003068743A1 Chemical compounds
08/21/2003WO2003068742A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
08/21/2003WO2003068732A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
08/21/2003WO2003068315A1 A pulmonary drug delivery composition containing a progestogen and an androgen for use in a contraceptive method in males
08/21/2003WO2003068230A1 Substituted pyridinones as modulators of p38 map kinase
08/21/2003WO2003068226A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003WO2003068217A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003WO2003068210A1 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
08/21/2003WO2003068202A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/21/2003WO2003068199A1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 557